Consistent patterns of change during the divergence of human immunodeficiency virus type 1 envelope from that of the inoculated virus in simian/human immunodeficiency virus-infected macaques

被引:50
作者
Blay, WM
Gnanakaran, S
Foley, B
Doria-Rose, NA
Korber, BT
Haigwood, NL
机构
[1] Seattle Biomed Res Inst, Viral Vaccines Program, Seattle, WA 98109 USA
[2] Univ Washington, Dept Pathobiol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
[4] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA
关键词
D O I
10.1128/JVI.80.2.999-1014.2006
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have analyzed changes to proviral Env gp120 sequences and the development of neutralizing antibodies (NAbs) during 1 year of simian/human immunodeficiency virus SHIV-89.6P infection in 11 Macaca nemestrina macaques. Seven macaques had significant env divergence from that of the inoculum, and macaques with greater divergence had higher titers of homologous NAbs. Substitutions in sequons encoding potential N-linked glycosylation sites (PNGs) were among the first to be established, although overall the total number of sequons did not increase significantly. The majority (19 of 23) of PNGs present in the inoculum were conserved in the sequences from all macaques. Statistically significant variations in PNGs occurred in multiple macaques within constrained regions we term "hot spots," resulting in the selection of sequences more similar to the B consensus. These included additions on V1, the N-terminal side of V4, and the outer region of C2. Complex mutational patterns resulted in convergent PNG shifts in V2 and V5. Charge changes in Env V1V2, resulting in a net acidic charge, and a proline addition in V5 occurred in several macaques. Molecular modeling of the 89.6P sequence showed that the conserved glycans lie on the silent face of Env and that many are proximal to disulfide bonds, while PNG additions and shifts are proximal to the CD4 binding site. Nonsynonymous-to-synonymous substitution ratios suggest that these changes result from selective pressure. This longitudinal and cross-sectional study of mutations in human immunodeficiency virus (HIV) env in the SHIV background provides evidence that there are more constraints on the configuration of the glycan shield than were previously appreciated.
引用
收藏
页码:999 / 1014
页数:16
相关论文
共 69 条
  • [1] Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia
    Allen, TM
    O'Connor, DH
    Jing, PC
    Dzuris, JL
    Mothé, BR
    Vogel, TU
    Dunphy, E
    Liebl, ME
    Emerson, C
    Wilson, N
    Kunstman, KJ
    Wang, XC
    Allison, DB
    Hughes, AL
    Desrosiers, RC
    Altman, JD
    Wolinsky, SM
    Sette, A
    Watkins, DI
    [J]. NATURE, 2000, 407 (6802) : 386 - 390
  • [2] Marked depletion of glycosylation sites in HIV-1 gp120 under selection pressure by the mannose-specific plant lectins of Hippeastrum hybrid and Galanthus nivalis
    Balzarini, J
    Van Laethem, K
    Hatse, S
    Froeyen, M
    Van Damme, E
    Bolmstedt, A
    Peumans, W
    De Clercq, E
    Schols, D
    [J]. MOLECULAR PHARMACOLOGY, 2005, 67 (05) : 1556 - 1565
  • [3] Mannose-specific plant lectins from the Amaryllidaceae family qualify as efficient microbicides for prevention of human immunodeficiency virus infection
    Balzarini, J
    Hatse, S
    Vermeire, K
    Princen, K
    Aquaro, S
    Perno, CF
    De Clercq, E
    Egberink, H
    Vanden Mooter, G
    Peumans, W
    Van Damme, E
    Schols, D
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (10) : 3858 - 3870
  • [4] Human immunodeficiency virus mutations during the first month of infection are preferentially found in known cytotoxic T-lymphocyte epitopes
    Bernardin, F
    Kong, D
    Peddada, L
    Baxter-Lowe, LA
    Delwart, E
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (17) : 11523 - 11528
  • [5] BOTARELLI P, 1991, J IMMUNOL, V147, P3128
  • [6] CROSS-REACTION BUT NO AVIDITY CHANGE OF THE SERUM ANTIBODY-RESPONSE AFTER INFLUENZA VACCINATION
    BROKSTAD, KA
    COX, RJ
    MAJOR, D
    WOOD, JM
    HAAHEIM, LR
    [J]. VACCINE, 1995, 13 (16) : 1522 - 1528
  • [7] SIMIAN IMMUNODEFICIENCY VIRUS MUTANTS RESISTANT TO SERUM NEUTRALIZATION ARISE DURING PERSISTENT INFECTION OF RHESUS-MONKEYS
    BURNS, DPW
    COLLIGNON, C
    DESROSIERS, RC
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (07) : 4104 - 4113
  • [8] EFFICIENT NEUTRALIZATION OF PRIMARY ISOLATES OF HIV-1 BY A RECOMBINANT HUMAN MONOCLONAL-ANTIBODY
    BURTON, DR
    PYATI, J
    KODURI, R
    SHARP, SJ
    THORNTON, GB
    PARREN, PWHI
    SAWYER, LSW
    HENDRY, RM
    DUNLOP, N
    NARA, PL
    LAMACCHIA, M
    GARRATTY, E
    STIEHM, ER
    BRYSON, YJ
    CAO, YZ
    MOORE, JP
    HO, DD
    BARBAS, CF
    [J]. SCIENCE, 1994, 266 (5187) : 1024 - 1027
  • [9] VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION
    CAO, YZ
    QIN, LM
    ZHANG, LQ
    SAFRIT, J
    HO, DD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) : 201 - 208
  • [10] Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies
    Chackerian, B
    Rudensey, LM
    Overbaugh, J
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (10) : 7719 - 7727